PGIM India CRISIL IBX Gilt Index - Apr 2028 Fund
Regular Plan · Regular IDCW · PGIM India Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.26% | +3.19% | 225 of 283 |
| 1M | +0.21% | +2.85% | 236 of 283 |
| 3M | +0.62% | -2.37% | 72 of 283 |
| 6M | +2.07% | +1.56% | 119 of 278 |
| YTD | -2.42% | -0.86% | 80 of 283 |
| 1Y | -1.62% | -0.15% | 63 of 263 |
| 2Y | -0.42% | +2.58% | 54 of 193 |
| 3Y | +0.37% | +9.71% | 130 of 142 |
| INCEPTION | +1.68% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +0.36% | +3.55% | -5.36% | 79% | 31% |
| 6M | +0.40% | +4.82% | -4.01% | 52% | 20% |
| 1Y | +0.85% | +8.22% | -6.40% | 71% | 28% |
| 2Y | +0.96% | +4.78% | -0.56% | 91% | 36% |
| 3Y | +0.73% | +3.28% | +0.14% | 100% | 40% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt95.70%
- Cash4.30%
- Other0.00%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| GOI LOAN 6.64% 2027 | Debt | 35.75% | -0.18% |
| 717GOI2028 | Debt | 31.42% | +0.33% |
| 828GOI2027 | Debt | 28.53% | -0.81% |
| Clearing Corporation of India Ltd. | Net Current Assets | 2.76% | — |
| Net Receivables / (Payables) | Net Current Assets | 1.54% | — |
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 5.86 | 12.38 | Low Volatility |
| 3Y | 6.34 | 10.25 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -1.17 | -0.51 | Below Average |
| 3Y | -0.81 | 0.26 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.26 | 12.56 | Below Average |
| 3Y | 0.09 | 8.16 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Tracking Difference
Versus CRISIL IBX Gilt Index - April 2028, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth
|
+13.22% | — | — | +7.26% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
More From PGIM India Asset Management Private Limite
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
PGIM India Healthcare Fund
Direct Plan · Direct Growth
|
+20.03% | — | — | +11.89% |
|
PGIM India Global Select Real Estate Securities Fund of Fund
Direct Plan · Direct Growth
|
+13.32% | +14.96% | — | +4.97% |
|
PGIM India Small Cap Fund
Direct Plan · Direct Growth
|
+9.52% | +15.36% | +11.72% | +13.35% |
|
PGIM India Arbitrage Fund
Direct plan · Growth
|
+6.56% | +7.03% | +6.51% | +6.11% |
|
PGIM India Liquid Fund
Direct Plan · Direct Growth
|
+6.53% | +6.94% | +6.46% | +6.26% |
|
PGIM India Money Market Fund
Direct Plan · Direct Growth
|
+6.20% | +7.11% | +6.66% | +6.12% |
|
PGIM India Ultra Short Term Fund
Direct Plan · Direct Growth
|
+6.16% | +7.00% | +6.52% | +7.30% |
|
PGIM India Multi Cap Fund
Direct Plan · Direct IDCW
|
+6.04% | — | — | +3.63% |
|
PGIM India Overnight Fund
Direct Plan · Direct Growth
|
+5.14% | +5.95% | +5.74% | +5.11% |
|
PGIM India Emerging Markets Equity Fund of Fund
Direct Plan · Direct Growth
|
+3.76% | +19.57% | +0.81% | +6.04% |
About This Scheme
Investment Objective
The investment objective of the scheme is to generate returns that corresponds to the total returns of the securities as represented by the CRISIL-IBX Gilt Index-April 2028 (before fees and expenses), subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Stated Asset Allocation
Securities comprising the CRISILIBX Gilt Index - April 2028 - Min 95% and Max 100% Money Market Instruments, Government securities, T- Bills, including Triparty Repo, cash and cash equivalents and units of liquid mutual fund- Min 0% and Max 5%
Exit Load
NIL
Fund Managers
Mr. Sandeep Devan and Mr. Puneet Pal
Description - Asset classwise we have different Fund Manager. Sandeep Devan is a Primary Fund Manager for Debt and Puneet Pal is Comanage Fund Manager for Debt.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch